Unbound MEDLINE

Activation of the adenosine A2A receptor attenuates experimental autoimmune myasthenia gravis severity.

Abstract

The adenosine A2A receptor (A2AR) is the major cellular adenosine receptor commonly associated with immunosuppression. Here, we investigated whether A2AR activation holds the potential for impacting the severity of experimental autoimmune myasthenia gravis (EAMG) induced following immunization of Lewis rats with the acetylcholine receptor (AChR) R97-116 peptide. This report demonstrates reduced A2AR expression by both T cells and B cells residing in spleen and lymph nodes following EAMG induction. A2AR stimulation inhibited anti-AChR antibody production and proliferation of AChR-specific lymphocytes in vitro. Inhibition was blocked with the A2AR antagonists or protein kinase A inhibitor. We also determined that the development of EAMG was accompanied by a T-helper cell imbalance that could be restored following A2AR stimulation that resulted in increased Treg cell levels and a reduction in Th1-, Th2-, and Th17-cell subtypes. An EAMG-preventive treatment regimen was established that consisted of (2-(p-(2-carbonylethyl)phenylethylamino)-5-N-ethylcarboxamidoadenosine) (CGS21680; A2AR agonist) administration 1 day prior to EAMG induction. Administration of CGS21680 29 days post EAMG induction (therapeutic treatment) also ameliorated disease severity. We conclude that A2AR agonists may represent a new class of compounds that can be developed for use in the treatment of myasthenia gravis or other T-cell- and B-cell-mediated autoimmune diseases.

Links

  • Publisher Full Text
  • Authors

    Li N, Mu L, Wang J, Zhang J, Xie X, Kong Q, Tang W, Yao X, Liu Y, Wang L, Wang G, Wang D, Jin L, Sun B, Li H

    Institution

    Department of Neurobiology, Harbin Medical University Provincial Key Lab of Neurobiology, Harbin Medical University, Heilongjiang, China.

    Source

    European journal of immunology 42:5 2012 May pg 1140-51

    MeSH

    Adenosine
    Adenosine A2 Receptor Agonists
    Adenosine A2 Receptor Antagonists
    Animals
    Antibodies, Neutralizing
    B-Lymphocytes
    Female
    Lymph Nodes
    Lymphocyte Activation
    Myasthenia Gravis, Autoimmune, Experimental
    Phenethylamines
    Rats
    Rats, Inbred Lew
    Receptor, Adenosine A2A
    Receptors, Cholinergic
    Severity of Illness Index
    Spleen
    T-Lymphocytes

    Pub Type(s)

    Journal Article
    Research Support, Non-U.S. Gov't

    Language

    eng

    PubMed ID

    22539289